← Back to Screener
Centene Corporation (CNC)
Price$38.31
Favorite Metrics
Price vs S&P 500 (26W)-2.01%
Price vs S&P 500 (4W)1.47%
Market Capitalization$18.75B
All Metrics
P/CF (Annual)3.79x
Book Value / Share (Quarterly)$40.57
P/TBV (Annual)1.31x
Revenue Growth (3Y)10.45%
Cash Flow / Share (Quarterly)$8.51
Price vs S&P 500 (YTD)-11.38%
Gross Margin (TTM)7.12%
Net Profit Margin (TTM)-3.43%
EPS (TTM)$-13.62
10-Day Avg Trading Volume4.95M
EPS Excl Extra (TTM)$-13.62
Revenue Growth (5Y)24.47%
EPS (Annual)$-13.53
ROI (Annual)-17.87%
Gross Margin (Annual)7.12%
Net Profit Margin (5Y Avg)0.45%
Cash / Share (Quarterly)$41.32
Revenue Growth QoQ (YoY)21.86%
ROA (Last FY)-8.70%
Revenue Growth TTM (YoY)19.44%
EBITD / Share (TTM)$-9.67
ROE (5Y Avg)-0.09%
Operating Margin (TTM)-3.91%
Cash Flow / Share (Annual)$8.51
P/B Ratio0.94x
P/B Ratio (Quarterly)1.01x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)0.09x
Net Interest Coverage (TTM)-8.92x
ROA (TTM)-8.03%
EV / EBITDA (TTM)3.88x
EPS Incl Extra (Annual)$-13.53
Current Ratio (Annual)1.10x
Quick Ratio (Quarterly)1.10x
3-Month Avg Trading Volume6.32M
52-Week Price Return-38.42%
EV / Free Cash Flow (Annual)4.37x
Revenue / Employee (TTM)$3
Tangible BV / Share (Quarterly)$31.36
P/S Ratio (Annual)0.10x
Asset Turnover (Annual)2.54x
52-Week High$64.15
Operating Margin (5Y Avg)0.50%
EPS Excl Extra (Annual)$-13.53
CapEx CAGR (5Y)-2.47%
Tangible BV CAGR (5Y)-2.37%
26-Week Price Return6.74%
Quick Ratio (Annual)1.10x
13-Week Price Return-17.33%
Total Debt / Equity (Annual)0.87x
Current Ratio (Quarterly)1.10x
Enterprise Value$18,259.367
Revenue / Share Growth (5Y)12.65%
Asset Turnover (TTM)2.34x
Book Value / Share Growth (5Y)-1.77%
Revenue / Employee (Annual)$3
Pretax Margin (Annual)-3.45%
Cash / Share (Annual)$41.32
3-Month Return Std Dev53.09%
Gross Margin (5Y Avg)10.29%
Net Income / Employee (TTM)$-0
ROE (Last FY)-33.45%
Net Interest Coverage (Annual)-8.92x
EPS Basic Excl Extra (Annual)$-13.53
P/FCF (TTM)4.48x
Receivables Turnover (TTM)10.30x
EV / Free Cash Flow (TTM)4.37x
Total Debt / Equity (Quarterly)0.87x
EPS Incl Extra (TTM)$-13.62
Receivables Turnover (Annual)10.30x
ROI (TTM)-15.98%
P/S Ratio (TTM)0.10x
Pretax Margin (5Y Avg)0.86%
Revenue / Share (Annual)$394.99
Tangible BV / Share (Annual)$31.36
Forward P/E12.69x
Free OCF CAGR (5Y)-2.03%
Price vs S&P 500 (52W)-73.51%
Year-to-Date Return-7.24%
5-Day Price Return1.87%
EPS Normalized (Annual)$-13.53
ROA (5Y Avg)0.36%
Net Profit Margin (Annual)-3.43%
Month-to-Date Return16.59%
Cash Flow / Share (TTM)$6.92
EBITD / Share (Annual)$-9.68
Operating Margin (Annual)-3.91%
LT Debt / Equity (Annual)0.87x
P/CF (TTM)3.79x
ROI (5Y Avg)0.30%
LT Debt / Equity (Quarterly)0.87x
EPS Basic Excl Extra (TTM)$-13.62
P/TBV (Quarterly)1.31x
P/B Ratio (Annual)1.01x
Pretax Margin (TTM)-3.45%
Book Value / Share (Annual)$40.57
Price vs S&P 500 (13W)-20.19%
Net Margin Growth (5Y)-10.04%
Beta0.69x
P/FCF (Annual)4.48x
Revenue / Share (TTM)$396.27
ROE (TTM)-27.74%
52-Week Low$25.08
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
3.31
3.35
3.35
3.35
Industry Peers — Hospital & Medical Insurance(9)
| Symbol | P/B Ratio (Quarterly) | ROE (TTM) | Indicated Dividend Yield (Annual) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
CNCCentene Corporation | 1.01x | -27.74% | — | -3.91% | $38.31 |
UNHUNITEDHEALTH GROUP INCORPORATED (Delaware) | 2.99x | 12.50% | 2.73% | 4.18% | $323.48 |
CIThe Cigna Group | 1.76x | 14.53% | 2.24% | 3.35% | $279.92 |
ELVElevance Health, Inc. | 1.78x | 13.01% | 2.13% | 4.07% | $319.36 |
HUMHumana Inc. | 1.74x | 6.59% | 1.68% | 2.03% | $210.34 |
MOHMolina Healthcare, Inc. | 2.19x | 10.99% | — | 1.72% | $150.12 |
OSCROscar Health, Inc. | 3.89x | -39.45% | — | -3.39% | $16.44 |
ALHCAlignment Healthcare, Inc. Common Stock | 22.04x | -0.49% | — | 0.37% | $21.56 |
TRUPTrupanion, Inc. | 4.20x | 5.39% | — | 0.98% | $28.88 |
CLOVClover Health Investments, Corp | 3.93x | -25.73% | — | -4.44% | $2.23 |
About
Centene Corporation is a managed care organization serving 22 million members through government-sponsored health plans, with revenue diversified across Medicaid (approximately 60% of membership), individual exchange plans (20%), Medicare, and military contracts. The company also provides Medicare Part D pharmaceutical coverage. As a leading platform in government-sponsored healthcare, Centene benefits from stable government reimbursement and recurring membership revenue.